Nxera Pharma Co., Ltd. (TYO:4565)
Japan · Delayed Price · Currency is JPY 905.00
+54.00 (6.35%)
At close: Mar 6, 2026
Nxera Pharma Market Cap
Nxera Pharma has a market cap or net worth of 81.9 billion as of March 6, 2026. Its market cap has decreased by -7.33% in one year.
Market Cap
81.90B
Enterprise Value
118.91B
Revenue
29.62B
Ranking
n/a
PE Ratio
n/a
Stock Price
905.00
Market Cap Chart
Since July 29, 2004, Nxera Pharma's market cap has increased from 38.40B to 81.90B, an increase of 113.30%. That is a compound annual growth rate of 3.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 81.90B | 9.43% |
| Dec 30, 2025 | 74.84B | -20.57% |
| Dec 30, 2024 | 94.22B | -25.87% |
| Dec 29, 2023 | 127.10B | -27.43% |
| Dec 30, 2022 | 175.15B | 12.85% |
| Dec 30, 2021 | 155.21B | 7.00% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PeptiDream | 170.76B |
| GNI Group | 165.62B |
| SanBio Company | 152.24B |
| Takara Bio | 138.00B |
| Oncolys BioPharma | 75.97B |
| Cuorips | 56.45B |
| Healios K.K. | 54.27B |
| Japan Tissue Engineering | 28.14B |